
View larger version (99K):
[in a new window]
|
Fig. 1. Human NIS (hNIS) secondary structure model and immunohistochemistry of thyroid tissue from the Q267E NIS patient. (A) Current WT hNIS 13-transmembrane-segment secondary structure model; ITD-causing mutations are shown in rectangles by the WT residue involved, indicating its position and the substituted residue. The single-letter amino acid code is used. X, stop codon; fS, frame shift; , deletion. (B-E) NIS expression was analyzed in paraffin-embedded sections of thyroid by immunohistochemistry using anti-carboxyl terminus hNIS Ab. (B) Normal thyroid staining. (C) Thyroid from a patient with Graves' disease and (D,E) thyroid from a patient with the Q267E NIS mutation (kindly provided by Dr Refetoff, Chicago University). Pronounced NIS protein staining was observed in both these cases. No immunoreactivity was detected in the presence of the C-terminus synthetic peptide (not shown). Magnifications: B,D, 250x; E,C, 1000x.
|